AccuVein

Executive Summary

AccuVein is a privately held medical device company that develops and commercializes vein visualization technology to improve peripheral intravenous (IV) access. Founded in 2006 and headquartered in Cold Spring Harbor, New York, the company addresses a critical clinical challenge: difficult IV starts, which are common in pediatric, elderly, and dark-skinned patients, leading to multiple attempts, patient discomfort, delayed treatment, and increased costs. AccuVein's handheld, non-invasive device projects a real-time map of underlying veins onto the skin's surface, enabling clinicians to locate veins more accurately and quickly. The company markets its product as the essential first step in improving patient experience, nurse well-being, and healthcare equity. While specific financials and market share are not publicly disclosed, the technology is widely adopted in hospitals and clinics across the United States and internationally. AccuVein operates in the competitive medical devices and diagnostics space, with opportunities for growth through product line extensions, expanded indications, and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026New product launch or next-generation device with enhanced imaging60% success
• Q4 2026Strategic partnership or distribution agreement with major hospital network50% success
• Q1 2027Publication of clinical study demonstrating improved first-attempt success rate and cost savings70% success